The world’s first FDA-approved cardiac monitoring device is set to launch in Australia.
‘The Guardian’ is an implanted device monitoring a patient’s heart signal 24/7 that can alert patients of an impending Acute coronary Syndrome event, including heart attacks and unstable angina.
Hydrix Chairman, Gavin Coote said coronary heart disease is the leading cause of death globally.
“The AngelMed Guardian will help save lives and lower overall healthcare costs,” Mr Coote said.